BOOKS BY CATEGORY
Your Account
Showing 8 of 8 results for "Series: Resistance to Targeted Anti-Cancer Therapeutics"
 
Sort by:
Published June, 2015
By Benjamin Bonavida and Salem Chouaib
Publisher: Springer (Springer International Publishing AG)
Series: Resistance to Targeted Anti-Cancer Therapeutics
Rating:

Availability: Available
This comprehensive volume explores the latest research on the mechanisms of resistance in cancer cells to CTL-mediated immunotherapy. In order for CTL-mediated antitumor immunotherapy to be effective, it is essential that agents directed against the resistant tumor cells sensitized cancer cells for CTL-mediated apoptosis.

Hardback
€158.59
Quantity: Add to basket  

This book will be a guide to understanding resistance against targeted therapeutic approaches for cancer using immunotoxins. As well, it includes an in-depth description of the molecular and cellular mechanisms involved in cancer resistance and several novel methods to overcome resistance.

Hardback
€146.39
Quantity: Add to basket  

Published May, 2015
By Alexey Larionov
Publisher: Springer (Springer International Publishing AG)
Series: Resistance to Targeted Anti-Cancer Therapeutics
Rating:

Availability: Available
Aromatase Inhibitors (AIs) treat postmenopausal estrogen receptor positive tumours, which constitute the majority of breast cancer patients. The second section provides the detailed mechanisms of resistance to AIs, while the third section explores prediction of resistance and potential strategies to overcome resistance.

Hardback
€146.39
Quantity: Add to basket  

Published April, 2015
By Giulio Jori, Valentina Rapozzi and Paola Jori
Publisher: Springer (Springer International Publishing AG)
Series: Resistance to Targeted Anti-Cancer Therapeutics
Rating:

Availability: Available
This volume provides a comprehensive review of resistance induced by photodynamic therapy (PDT) in tumor cells. Studies reveal that PDT can be curative, particularly in early stage tumors and this volume explores the potential of PDT, but also reveals strategic approaches to overcome resistance in tumor cells.

Hardback
€158.59
Quantity: Add to basket  

Published November, 2014
By Thomas Efferth
Publisher: Springer (Springer International Publishing AG)
Series: Resistance to Targeted Anti-Cancer Therapeutics
Rating:

Availability: Available
This critical review volume explores the theme of ABC transporters in the context of basic cancer research and its role in drug-resistant tumors.

Hardback
€158.59
Quantity: Add to basket  

Published September, 2014
By Q. Ping Dou
Publisher: Springer (Springer International Publishing AG)
Series: Resistance to Targeted Anti-Cancer Therapeutics
Rating:

Availability: Available
Resistance to Proteasome Inhibitors in Cancer

Hardback
€182.99
Quantity: Add to basket  

Published August, 2013
By Benjamin Bonavida
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Resistance to Targeted Anti-Cancer Therapeutics
Rating:

Availability: Available
The book covers the common and unique features of mAbs agains various cancer, gives the latest developments on the molecular, biochemical and genetic mechanisms of resistance by various mAbs, as well as discuss novel mAbs to overcome resistance.

Hardback
€182.99
Quantity: Add to basket  
€134.19
Quantity: Add to basket  

Published April, 2013
By Benjamin Bonavida
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Resistance to Targeted Anti-Cancer Therapeutics
Rating:

Availability: Available
These mechanisms should reveal gene products that directly regulate resistance in order to develop new drugs that target these resistance factors and such new drugs may either be selective or common to various cancers.

Hardback
€170.79
Quantity: Add to basket  
€146.39
Quantity: Add to basket